Organization: The University of Adelaide, Australia
Title:
Biography:
Dr Katharina Richter is a biomedical researcher with global work stints in Germany, New Zealand, Switzerland, Denmark, Belgium and Australia. A trained pharmacist she completed her PhD in medicine/applied microbiology in 2017 and founded her own research group in 2019 at the University of Adelaide.
Katharina has won numerous awards for excellence in science, innovation and science communication, including Innovator Under 35 Asia-Pacific, SA Science Excellence Award for PhD Researcher of the Year, SA Young Tall Poppy Science Award, Women in Innovation Award and many more.
Superbugs, or antibiotic-resistant bacteria, pose one of the greatest threats to human health worldwide, causing over 1.3 million deaths every year. Bacteria naturally reside in biofilms as complex communities encased in a self-assembled slime. This lifestyle protects bacteria from medical therapies and promotes resistance contributing to therapeutic failure and exacerbation. The rise of superbugs stresses the need for novel treatments.
The Richter Lab is dedicated to improve medical therapies, changing the lives of patients suffering from superbug infections, such as surgical site infections, non-healing wounds and implant infections.
We furthermore collaborate with veterinary scientists to innovate industry decontamination processes for better animal wellbeing and safer, more sustainable food production.
Our research focus is on i) developing effective treatments against antibiotic-resistant bacteria and translating them from the lab to real-life applications, and ii) improving health literacy of the society by effective science communication through public speaking, science outreach activities and STEM workshops at schools.
We collaborate widely in multidisciplinary teams of scientists, clinicians and industry partners to ensure a real-world impact of our work.